Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2005
09/27/2005US6949633 Primers useful for sizing nucleic acids
09/27/2005US6949632 Fluorogenic substrate for use as diagnostic tools in the analysis of enzymatic activity
09/27/2005US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
09/27/2005US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor
09/27/2005US6949385 Thermal microvalves
09/27/2005US6949382 for providing biochemical analysis of antioxidant function in human lymphocytes
09/27/2005US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP)
09/27/2005US6949376 Nucleic acid amplification reaction station for disposable test devices
09/27/2005US6949373 given amino acid sequence; telomerase motif; use as drug target for cancer
09/27/2005US6949370 High fidelity thermostable ligase and uses thereof
09/27/2005US6949368 Compositions and methods for enhancing polynucleotide amplification reactions
09/27/2005US6949367 incubating a polynucleotide containing a target sequence with one or more modified oligonucleotide primers complementary to the target sequence, in the presence of a polymerizing enzyme and nucleotide substrates
09/27/2005US6949361 Polynucleotide
09/27/2005US6949357 Reagents and methods useful for detecting diseases of the urinary tract
09/27/2005US6949354 Detection of nervous system modulators; obtain preferential nervous system tissue in vitro, culture, incubate with modulator, monitor and evaluate adjustment in cell activity
09/27/2005US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase
09/27/2005US6949351 adding adenosine diphosphate (ADP) to a sample which allows the conversion of ADP to adenosine triphosphate (ATP) by cellular adenylate kinase, detecting ATP in the sample and relating amount of ATP detected to the presence of adenylate kinase
09/27/2005US6949344 Hair analysis method
09/27/2005US6949343 Self-complementary arm segments and flexible linkages that promote intramolecular or intermolecular interactions; probe-based nucleic acid sequence detection, analysis and quantitation
09/27/2005US6949342 Prostate cancer diagnosis and outcome prediction by expression analysis
09/27/2005US6949340 for diagnosis of disease and genetic predisposition to disease, forensic or paternity testing and genetic analyses, for example breeding or engineering stock improvements in plants and animals
09/27/2005US6949339 Method of diagnosing, monitoring, and staging colon cancer
09/27/2005US6949338 Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids
09/27/2005US6949336 ligases; genetic engineering; immunassays/bioassays; drug screening
09/27/2005US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections
09/27/2005US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates
09/27/2005US6949221 Method of making a test strip for determining analyte concentration over a broad range of sample volumes
09/27/2005CA2428206C Methods for the treatment of cellular proliferative disorders
09/27/2005CA2245680C Method of detection of influenza virus and compounds for use therein
09/22/2005WO2005088306A2 Biologically-active dna-binding sites and related methods
09/22/2005WO2005088305A1 Method of stabilizing oxidizable color-assuming reagent
09/22/2005WO2005088301A1 Method for detection of malaria and other parasite infections
09/22/2005WO2005088299A1 Method of assaying dermal permeability of transdermal drug mediated by dermal transporter
09/22/2005WO2005087953A2 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
09/22/2005WO2005087952A1 Methods and compositions relating to the pharmacogenetics of abcc2, ugt1a1, and/or slc01b1 gene variants
09/22/2005WO2005087951A2 Reagents, methods and kits for use in deactivating nucleic acids
09/22/2005WO2005087950A1 Method of detecting nucleic acid using amplification on an array
09/22/2005WO2005087949A1 Systematic mapping of adenosine to inosine editing sites in the human transcriptome
09/22/2005WO2005087948A2 Cancer treatment and assays for determining resistance to platinum-based chemotherapeutic agent
09/22/2005WO2005087946A1 Method of measuring glycoprotein
09/22/2005WO2005087945A1 Method for selective amplification of dna frangments for genetic fingerprinting
09/22/2005WO2005087944A1 Quality ensurement system for detecting microorganisms
09/22/2005WO2005087943A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
09/22/2005WO2005087933A1 Thiol methyltransferase-based selection
09/22/2005WO2005087930A1 Polynucleotides for the detection of escherichia coli o157
09/22/2005WO2005087929A1 Infectious aetiology of prostatic disease and methods to identify causative agents
09/22/2005WO2005087928A1 Proteins imparting boron-tolerance and genes thereof
09/22/2005WO2005087807A1 Vr1 receptors and uses thereof
09/22/2005WO2005087806A2 Cd38 splice variant and uses thereof
09/22/2005WO2005087790A1 A nucleotide specific for o-antigen of escherichia coli o114 type
09/22/2005WO2005087789A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome
09/22/2005WO2005087784A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
09/22/2005WO2005087725A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087251A1 Compositions and methods for inhibiting abnormal cell growth
09/22/2005WO2005086954A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
09/22/2005WO2005086938A2 Artificial mutation controls for diagnostic testing
09/22/2005WO2005086907A2 Biosynthetic gene cluster for ambruticins
09/22/2005WO2005086896A2 Delivery vectors for short interfering rna, micro-rna and antisense rna
09/22/2005WO2005086891A2 Classification of breast cancer patients using a combination of clinical criteria and informative genesets
09/22/2005WO2005086872A2 Ptpn22 polymorphisms in diagnosis and therapy
09/22/2005WO2005086830A2 Raman-enhancing, and non-linear optically active nano-sized optical labels and uses thereof
09/22/2005WO2005086827A2 Methods of assessing the need for and the effectiveness of therapy with antioxidants
09/22/2005WO2005086798A2 Improved interleukin-2 muteins
09/22/2005WO2005086794A2 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
09/22/2005WO2005086784A2 Method and apparatus for measuring changes in cell volume
09/22/2005WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery
09/22/2005WO2005086770A2 Methods for genetic analysis
09/22/2005WO2005086751A2 Combinatorial interleukin-2 muteins
09/22/2005WO2005086679A2 Methods and compositions for assessing nucleic acids and alleles
09/22/2005WO2005086674A2 Brhf1 as a cancer diagnostic marker
09/22/2005WO2005086667A2 High efficiency peptide production in plant cells
09/22/2005WO2005086647A2 Immuno-pcr method for the detection of a biomolecule in a test sample
09/22/2005WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
09/22/2005WO2005080604A3 Genetic analysis by sequence-specific sorting
09/22/2005WO2005072097A9 Toll-like receptor 9 modulators
09/22/2005WO2005069855A3 Modulators of angiogenesis
09/22/2005WO2005068657A3 Genetically profiled cell lines (gpcl) and methods of utilizing same for genetic dissection of cellular phenotypes
09/22/2005WO2005059182A3 Reagents and methods for detecting neisseria gonorrhoeae
09/22/2005WO2005045054A3 Methods for identifying active substances for influencing body mass and obesity
09/22/2005WO2005043973A3 Assay systems and methods for detecting molecules that interact with sk2 channels
09/22/2005WO2005032330A3 Zintrodes, multitrodes and uses thereof
09/22/2005WO2005031362A3 Novel antibacterial agents and methods of identifying and utilizing same
09/22/2005WO2005031004A3 Method for the specific rapid detection of beverage-spoiling micro-organisms
09/22/2005WO2005024068A3 Allele-specific sequence variation analysis
09/22/2005WO2005017183A3 Methylated gene biomarkers for detecting cancer
09/22/2005WO2005014786A3 Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes
09/22/2005WO2004113557A3 Methods and systems for the analysis of biological sequence data
09/22/2005WO2004096995A3 Recombinant plant dicer
09/22/2005WO2004083806A3 Autonomous genosensor apparatus and methods for use
09/22/2005WO2004044178A3 Methods and compositions for diagnosing dysplasia
09/22/2005WO2003065997A3 Anti-infarction molecules
09/22/2005US20050210548 Hydrolase expressed in transgenic plants for improving feed digestibility in baking and brewing
09/22/2005US20050210540 Expression vector comprising nucleotide sequence coding glycine transport protein for use in generating animal models which identify modulators of psychotic behavior
09/22/2005US20050210538 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders
09/22/2005US20050209787 Sequencing data analysis
09/22/2005US20050209448 Secretion, transcription and sporulation genes in bacillus clauslii
09/22/2005US20050209280 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209182 Inhibits bacterial subtilisn type serine protease CylA activity; siRNA, antisense, and enzymatic nucleic acid molecules that can modulate the expression of CylA genes
09/22/2005US20050209181 Compositions and methods for diagnosing and treating mental disorders